$CVEO

Civeo Reports Second Quarter 2026 Results

Civeo (NYSE:CVEO) reported Q2 2026 revenues of $180.0M, net loss of $2.5M, and Adjusted EBITDA of $23.8M. Revenues rose 11% year over year, helped by integrated services and higher Canada occupancy. After quarter-end, it issued $115.0M 4.50% convertible notes due 2031 and repurchased 660,297 shares for about $22.3M.

Original reporting
Published Jul 30, 2026, 11:00 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 30, 2026, 11:55 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Civeo Reports Second Quarter 2026 Results — source image
Decision brief

The 30-second read

$CVEONeutralMed
01

Why it matters

Q2 results show revenue growth but Adjusted EBITDA pressure from Canada integrated services contract start-up costs and Australia occupancy headwinds tied to diesel price uncertainty. The post-quarter-end $115M convertible notes issuance at a 20% premium and concurrent buybacks change the capital structure and may affect dilution expectations and near-term leverage optics. Full-year 2026 guidance is maintained.

02

Market read

Traders can update models for 2H 2026 based on segment drivers, and reprice capital structure risk after the convertible issuance and buyback execution details.

03

What to watch

The article highlights FX tailwinds and LNG-related room strength; traders may underweight how much of the improvement is non-recurring versus underlying demand trends into 2H 2026.

Relevance 8/10Novelty 8/10Timing: after-hours/market-open positioning today on Q2 print plus July 2026 convertible issuance and buyback details

Background

Civeo is a workforce housing provider with operations in Australia and Canada, increasingly emphasizing integrated services tied to energy and infrastructure projects.

Company-level read

Ticker impact

$CVEONeutralMedium confidence
Context

Civeo reported Q2 2026 results and, after quarter-end, issued $115M 4.50% convertible notes plus concurrent share repurchases.

Expected impact

Moderate two-sided reaction risk: positive from fixed-rate funding and buyback completion, offset by weaker Adjusted EBITDA drivers and start-up costs.

Evidence & confidence

The article discloses concrete financing terms, repurchase size, and segment-level EBITDA drivers, but it does not provide a new full-year guidance change beyond maintaining prior ranges.

Market effects

Could influence sentiment toward lodging and workforce housing operators tied to energy and infrastructure demand, especially where integrated services are expanding.

Canada demand strength is tempered by new contract start-up costs; Australia results are sensitive to FX and diesel-related customer caution.

Limited direct global spillover; primarily affects North American energy-infrastructure labor housing expectations.

Counterpoint

The convertible issuance and buyback may be more about managing near-term liquidity and leverage optics than signaling durable operating improvement, given EBITDA headwinds from contract start-ups and occupancy softness.

Key entities

  • Civeo Corporation

    Reported Q2 2026 revenues of $180.0M, net loss of $2.5M, and Adjusted EBITDA of $23.8M, and disclosed $115M convertible notes plus share repurchases.

Related articles

$CVEOMedAI 8/10

Civeo (CVEO) Q2 2026 Earnings Call Transcript

Thursday, July 30, 2026 at 9:30 a.m. ET CALL PARTICIPANTS President and Chief Executive Officer - Bradley Dodson Chief Financial Officer and Treasurer - Collin Gerry Vice President, Corporate Development - Regan Nielsen TAKEAWAYS Total Revenue -- $180 million, representing an 11% increase from $162.7 million in the prior year period. Net Loss -- $2.5 million, compared to a net loss of $3.3 million in the second quarter of 2025.

$CVEOMed

Civeo Corp (CVEO): Results of Operations and Financial Condition

Civeo Corp (CVEO) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 cveo-06302026xrelease.htm EX-99.1 Document Civeo Reports Second Quarter 2026 Results Highlights: • Reported revenues of $180.0 million, net loss of $2.5 million and Adjusted EBITDA of $23.8 million; • Consolidated revenues increased 11%, driven by integrated services gr

$CVEOMedAI 8/10

Civeo Corporation Prices $100.0 Million Convertible Senior Notes Offering

Civeo (NYSE: CVEO) priced a $100.0 million offering of 4.50% convertible senior notes due 2031 in a Rule 144A private placement, settling July 7, 2026. Notes convert at 24.6840 shares per $1,000 (initial conversion price ~$40.51), ~20% above $33.76. Net proceeds ~$96.2 million; up to $110.8 million with option. Proceeds: $22.3 million to repurchase 660,297 shares and remainder to repay debt.

$CVEOMedAI 8/10

Civeo Awarded Six-Year Western Canada Contract Renewal

Civeo Corporation (NYSE: CVEO) said a Western Canada joint venture received a six-year contract renewal to provide workforce accommodations and hospitality services. The agreement runs through June 30, 2032, replacing arrangements due to expire in 2027, and covers services across Civeo’s Western Canada lodge network.

$KDMed

Kyndryl Q1 Earnings Call Highlights

Kyndryl (NYSE:KD) Q1 call said demand is rising for AI deployment, hybrid modernization, cybersecurity and data-residency. It reported 40 deals worth over $50M in 12 months, with 10 in Q1, and Kyndryl Consult signings up 50%. IBM relationship changes are expected to weigh on constant-currency revenue through FY2027. FCF was -$401M; cash $2.1B. Outlook FY2027 reaffirmed.

$KAIMedAI 8/10

Kadant Q2 Earnings Call Highlights

Kadant (NYSE:KAI) reported Q2 equipment backlog of $182 million and said aftermarket demand stayed at record or near-record levels. Flow Control revenue rose 5% to $100 million; Industrial Processing revenue rose to a record $144 million; Material Handling bookings were $73 million. Q2 gross margin fell to 43.8%. Kadant raised FY revenue guidance to $1.19-$1.21B and adjusted EPS to $12.43-$12.68.